Key Metrics
CiteScore 

5.2
H-Index 

65
Impact Factor 

< 5
SJR 

Q2Drug Discovery

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on Drug Development Research
Drug Development Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1981 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Development Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Development Research
Title not available
- 1 May 2026
- Drug Development Research
FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
- 1 May 2026
- Drug development research
DPP4-Driven Ferroptosis Promotes Senescence: Galangin as a Therapeutic Agent for Age-Related Bone Loss.
- 1 May 2026
- Drug development research
Discovery of Tetrahydropyrrolo[3,4-c]pyrrole-1,3-dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore-Based Virtual Screening.
- 27 Apr 2026
- Drug development research
Secoisolariciresinol Diglucoside Alleviates LPS-Induced Acute Lung Injury by Inhibiting the NF-κB/NLRP3 Signaling Pathway.
- 27 Apr 2026
- Drug development research
Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple-Negative Breast Cancer Through Modulating HIF-1α/MMP-9 Pathway.
- 27 Apr 2026
- Drug development research
Title not available
- 1 May 2026
- Drug Development Research
FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
- 1 May 2026
- Drug development research
DPP4-Driven Ferroptosis Promotes Senescence: Galangin as a Therapeutic Agent for Age-Related Bone Loss.
- 1 May 2026
- Drug development research
Discovery of Tetrahydropyrrolo[3,4-c]pyrrole-1,3-dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore-Based Virtual Screening.
- 27 Apr 2026
- Drug development research
Secoisolariciresinol Diglucoside Alleviates LPS-Induced Acute Lung Injury by Inhibiting the NF-κB/NLRP3 Signaling Pathway.
- 27 Apr 2026
- Drug development research
Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple-Negative Breast Cancer Through Modulating HIF-1α/MMP-9 Pathway.
- 27 Apr 2026
- Drug development research